Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Lenograstim adverse reaction |
Causative agent (attribute) |
True |
Lenograstim (substance) |
Inferred relationship |
Some |
1 |
Allergy to lenograstim |
Causative agent (attribute) |
False |
Lenograstim (substance) |
Inferred relationship |
Some |
|
Product containing lenograstim (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lenograstim (substance) |
Inferred relationship |
Some |
1 |
Lenograstim 263micrograms powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lenograstim (substance) |
Inferred relationship |
Some |
|
Lenograstim 105micrograms powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lenograstim (substance) |
Inferred relationship |
Some |
|
Allergy to lenograstim |
Causative agent (attribute) |
True |
Lenograstim (substance) |
Inferred relationship |
Some |
1 |
Lenograstim 263micrograms powder for conventional release solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lenograstim (substance) |
Inferred relationship |
Some |
|
Product containing precisely lenograstim 13.4 million unit/1 vial powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Lenograstim (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely lenograstim 13.4 million unit/1 vial powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Lenograstim (substance) |
Inferred relationship |
Some |
1 |
Lenograstim-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lenograstim (substance) |
Inferred relationship |
Some |
1 |
Product containing only lenograstim (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lenograstim (substance) |
Inferred relationship |
Some |
1 |
Product containing only lenograstim in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lenograstim (substance) |
Inferred relationship |
Some |
1 |
Lenograstim 33.6 million unit powder for solution for infusion vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Lenograstim (substance) |
Inferred relationship |
Some |
1 |
Lenograstim 33.6 million unit powder for solution for infusion vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Lenograstim (substance) |
Inferred relationship |
Some |
1 |